Reflex hepatitis C virus viral load testing following an initial positive hepatitis C virus antibody test: A global systematic review and meta-analysis

Y Tao, W Tang, E Fajardo, M Cheng… - Clinical Infectious …, 2023 - academic.oup.com
Background Many people who have a positive hepatitis C virus (HCV) antibody (Ab) test
never receive a confirmatory HCV RNA viral load (VL) test. Reflex VL testing may help …

[图书][B] Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and HCV diagnostics

World Health Organization - 2022 - books.google.com
Page 1 World Health Organization UPDATED RECOMMENDATIONS ON TREATMENT OF
ADOLESCENTS AND CHILDREN WITH CHRONIC HCV INFECTION, AND HCV SIMPLIFIED …

Hepatitis C diagnosis: simplified solutions, predictive barriers, and future promises

I Shahid, AR Alzahrani, SS Al-Ghamdi, IM Alanazi… - Diagnostics, 2021 - mdpi.com
The simplification of current hepatitis C diagnostic algorithms and the emergence of digital
diagnostic devices will be very crucial to achieving the WHO's set goals of hepatitis C …

Who should be prioritised for COVID-19 vaccines?

Z Hassan-Smith, W Hanif, K Khunti - The Lancet, 2020 - thelancet.com
As effective vaccines and preventive medications become available for COVID-19, demand
is likely to outstrip supply, so we need to develop a strategy to prioritise their use to ensure …

Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia

F Averhoff, S Shadaker, A Gamkrelidze… - Journal of …, 2020 - Elsevier
Background & Aims Georgia, with a high prevalence of HCV infection, launched the world's
first national hepatitis C elimination program in April 2015. A key strategy is the identification …

[PDF][PDF] Hepatitis C virus elimination by 2030: conquering mount improbable

RK Dhiman, M Premkumar - Clinical liver disease, 2020 - Wiley Online Library
Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable Page 1 254 |CliniCal
liver Disease, vOl 16, nO 6, DeCeMBer 2020 An Official Learning Resource of AASLD review …

Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting

RK Dhiman, GS Grover, M Premkumar, S Taneja… - Journal of …, 2019 - Elsevier
Background & Aims The prevalence of anti-hepatitis C virus antibody in Punjab, India is
3.6%, with 728,000 people estimated to have viremic chronic hepatitis C (CHC). The Mukh …

Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three‐arm study

S Shilton, J Markby, M Japaridze, V Chihota… - Liver …, 2022 - Wiley Online Library
Abstract Background and Aims In 2015, Georgia began a hepatitis C virus (HCV) elimination
programme. Although screening programmes have been decentralized for high‐risk groups …

Hepatitis C vaccine: 10 good reasons for continuing

P Roingeard, E Beaumont - Hepatology, 2020 - journals.lww.com
Conclusions Mass spectrometric analysis identified serine 335 in the SDS1 region of mNrf2
as the major phosphorylation site for modulation of Nrf2 ubiquitylation by P‐JNK. This study …

[HTML][HTML] Current and future strategies for the treatment of chronic hepatitis C

O Alshuwaykh, PY Kwo - Clinical and Molecular Hepatology, 2021 - ncbi.nlm.nih.gov
Chronic hepatitis C infection is a major cause of liver disease and hepatocellular carcinoma
worldwide. While hepatitis C has been treated for decades with some success, the …